CA1085406A - Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate - Google Patents

Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate

Info

Publication number
CA1085406A
CA1085406A CA264,921A CA264921A CA1085406A CA 1085406 A CA1085406 A CA 1085406A CA 264921 A CA264921 A CA 264921A CA 1085406 A CA1085406 A CA 1085406A
Authority
CA
Canada
Prior art keywords
ester
formula
isobutyl
dihydro
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA264,921A
Other languages
English (en)
French (fr)
Inventor
Egbert Wehinger
Friedrich Bossert
Arend Heise
Stanislav Kazda
Kurt Stoepel
Wulf Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA1085406A publication Critical patent/CA1085406A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA264,921A 1975-11-05 1976-11-04 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate Expired CA1085406A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP2549568.5 1975-11-05
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CA1085406A true CA1085406A (en) 1980-09-09

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
CA264,921A Expired CA1085406A (en) 1975-11-05 1976-11-04 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate

Country Status (27)

Country Link
JP (1) JPS5259161A (cs)
AT (1) AT352129B (cs)
AU (1) AU498964B2 (cs)
BE (1) BE847968A (cs)
BG (6) BG25078A3 (cs)
CA (1) CA1085406A (cs)
CH (2) CH623038A5 (cs)
CS (1) CS200499B2 (cs)
DE (1) DE2549568C3 (cs)
DK (1) DK146762C (cs)
ES (2) ES452986A1 (cs)
FI (1) FI60704C (cs)
FR (1) FR2330395A1 (cs)
GB (1) GB1516793A (cs)
GR (1) GR61241B (cs)
HK (1) HK12681A (cs)
IE (1) IE43984B1 (cs)
IL (1) IL50817A (cs)
LU (2) LU76133A1 (cs)
NL (2) NL175915C (cs)
NO (1) NO145574C (cs)
NZ (1) NZ182502A (cs)
PL (2) PL105940B1 (cs)
PT (1) PT65797B (cs)
RO (1) RO70295A (cs)
SE (1) SE423542B (cs)
ZA (1) ZA766622B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社 扉
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE2549568A1 (de) 1977-05-18
IE43984L (en) 1977-05-05
PT65797B (de) 1978-05-12
AU1935876A (en) 1978-05-11
BG24805A3 (en) 1978-05-12
DE2549568C3 (de) 1981-10-29
AT352129B (de) 1979-09-10
ATA814276A (de) 1979-02-15
HK12681A (en) 1981-04-10
FI60704C (fi) 1982-03-10
GB1516793A (en) 1978-07-05
SE7612308L (sv) 1977-05-06
NO145574B (no) 1982-01-11
DK146762B (da) 1983-12-27
BG24804A3 (en) 1978-05-12
NO145574C (no) 1982-04-21
FI60704B (fi) 1981-11-30
FI763160A (cs) 1977-05-06
LU76133A1 (cs) 1977-06-02
BE847968A (fr) 1977-05-04
SE423542B (sv) 1982-05-10
BG24668A3 (en) 1978-04-12
IL50817A (en) 1979-07-25
JPS5647185B2 (cs) 1981-11-07
NL930035I1 (nl) 1993-08-02
PL106084B1 (pl) 1979-11-30
CH623038A5 (en) 1981-05-15
PT65797A (de) 1976-12-01
NO763608L (cs) 1977-05-06
GR61241B (en) 1978-10-12
NL175915C (nl) 1985-01-16
FR2330395B1 (cs) 1978-12-22
JPS5259161A (en) 1977-05-16
BG24803A3 (en) 1978-05-12
ZA766622B (en) 1977-10-26
IE43984B1 (en) 1981-07-15
BG25078A3 (en) 1978-07-12
NZ182502A (en) 1978-07-28
CS200499B2 (en) 1980-09-15
IL50817A0 (en) 1977-01-31
PL105940B1 (pl) 1979-11-30
DE2549568B2 (de) 1980-08-21
BG25079A3 (en) 1978-07-12
ES452986A1 (es) 1977-12-16
DK146762C (da) 1984-06-12
NL7612198A (nl) 1977-05-09
AU498964B2 (en) 1979-03-29
FR2330395A1 (fr) 1977-06-03
DK498476A (da) 1977-05-06
NL930035I2 (nl) 1993-10-01
RO70295A (ro) 1981-08-17
ES463166A1 (es) 1978-07-16
LU88275I2 (cs) 1994-02-03
CH622779A5 (en) 1981-04-30

Similar Documents

Publication Publication Date Title
US4532248A (en) Method of combatting coronary and vascular diseases
US4849433A (en) The compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilation
US4705797A (en) N-(3,3-diphenylpropyl) aminoethyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid, compositions and use
FI61483C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,-dihydropyridinkarboxylsyraaralkylestrar
IL41668A (en) N-Transformed History of Dihydropyridine, Their Manufacture, and Pharmaceutical Preparations Containing Them
IL42458A (en) 1,4-dihydropyridines their production and pharmaceutical compositions containing them
CA1130291A (en) Fluorine-containing 1,4-dihydropyridine compounds, their production and their medicinal use
CA1108615A (en) Dihydropyridine compounds, their production and their medicinal use
CA1085406A (en) Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate
EP0097821B1 (en) Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them
HU176454B (en) Process for preparing 1,4-dihydro-pyridine derivatives
CA1175438A (en) 1,4-dihydropyridine compounds having different substituents in the 2-position and 6-position, their production, and their medicinal use
HU178532B (en) Process for producing 1,2,4,5-tetraalkyl-4-aryl-piperidine derivatives
US4237137A (en) Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use
EP0197488A2 (en) 1,4-Dihydropyiridine derivative, a process for preparing the same, a pharmaceutical composition as well as the use thereof
CA1258263A (en) 2-nitro-oxyalkyl-1,4-dihydropyridine derivatives
US4166855A (en) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator
US4364952A (en) Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use
IL46593A (en) 2-amino-6-dialkylamino-dihydropyridines their production and pharmaceutical compositions containing them
NZ204284A (en) Dihydropyridine derivatives and pharmaceutical compositions
JPS6352031B2 (cs)
EP0212340A1 (en) 2-(heteroalkyl)-1,4-dihydropyridines, process for their preparations and pharmaceutical compositions containing them
JPH0714931B2 (ja) 新規ジヒドロピリジン誘導体、その製法および用途
EP0220917B1 (en) 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof
US4675329A (en) Isopropyl 2-(3-trifluoromethylphenoxy)-ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate as vaso-dilators

Legal Events

Date Code Title Description
MKEX Expiry